Jubilant Ingrevia Intrinsic Value
JUBLINGREA • Chemicals
Current Stock Price
₹630.05
Primary Intrinsic Value
₹211.20
Market Cap
₹1008 Cr
+100.0%
Upside
Median Value
₹1260.10
Value Range
₹189 - ₹1575
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
JUBLINGREA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹211.20 | ₹168.96 - ₹253.44 | -66.5% | EPS: ₹17.60, Sector P/E: 12x |
| Book Value Method | asset | ₹1575.12 | ₹1417.61 - ₹1732.63 | +150.0% | Book Value/Share: ₹1829.38, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1260.10 | ₹1134.09 - ₹1386.11 | +100.0% | Revenue/Share: ₹2802.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1260.10 | ₹1134.09 - ₹1386.11 | +100.0% | EBITDA: ₹540.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1575.12 | ₹1260.10 - ₹1890.14 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹189.01 | ₹170.11 - ₹207.91 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹189.01 | ₹170.11 - ₹207.91 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1260.10 | ₹1134.09 - ₹1386.11 | +100.0% | ROE: 9.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹851.14 | ₹766.03 - ₹936.25 | +35.1% | EPS: ₹17.60, BVPS: ₹1829.38 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
JUBLINGREA Intrinsic Value Analysis
What is the intrinsic value of JUBLINGREA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jubilant Ingrevia (JUBLINGREA) is ₹1260.10 (median value). With the current market price of ₹630.05, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹189.01 to ₹1575.12, indicating ₹189.01 - ₹1575.12.
Is JUBLINGREA undervalued or overvalued?
Based on our multi-method analysis, Jubilant Ingrevia (JUBLINGREA) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.89x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Jubilant Ingrevia
Additional stock information and data for JUBLINGREA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹508 Cr | ₹314 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹430 Cr | ₹146 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹463 Cr | ₹229 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹453 Cr | ₹418 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹112 Cr | ₹112 Cr | Positive Free Cash Flow | 8/10 |